NCT00953043View on ClinicalTrials.gov

Lubiprostone, Colonic Motility and Sensation

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2009

Conditions
Healthy
Interventions
DRUG

lubiprostone

Lubiprostone 24 micrograms, one dose daily for three days in 30 subjects

DRUG

Placebo

Placebo medication given for three days

OTHER

Bowel preparation

Polyethylene glycol-based bowel preparation

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

National Center for Research Resources (NCRR)

NIH

collaborator

Takeda

INDUSTRY

lead

Mayo Clinic

OTHER